Lipotropic Blend: These injections contain a carefully crafted lipotropic blend that includes methionine, inositol, and choline
Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
Downstream Signaling Pathway Research The PI3K/Akt/mTOR axis activated by IGF1R is one of the most thoroughly characterized signaling pathways in cell biology
Details of primary antibodies are provided in Table S1
Living in a rural area, I had been driving a 140 mile round trip each week to get shots administered for a much higher pricetag in a clinic in the city nearest to me